June 19, 2025

It’s pretty easy to get DeepSeek to talk dirty

AI companions like Replika are designed to engage in intimate exchanges, but people use general-purpose chatbots for sex talk too, despite their stricter content moderation policies. Now new research shows that not all chatbots are equally willing to talk dirty: DeepSeek is the easiest to convince. But other AI chatbots can be enticed too, if…

Practice your startup pitch on TechCrunch Live with Vanta and Sequoia

February 13, 2023

Practice pitching your startup on this week’s TechCrunch Live. I have two amazing guests and they bring along a lot of startup pitching experience. Three guests of this week’s TechCrunch Live event will have two minutes to practice their elevator pitch and they’ll get four minutes of candid feedback from the two guests. This week, […]

Practice your startup pitch on TechCrunch Live with Vanta and Sequoia by Matt Burns originally published on TechCrunch

32 Ways for Kids to Earn Money in 2023

February 13, 2023
It’s time to talk about how your kids can make money. Why? There is no denying that life with kids can be expensive. Besides wanting the latest (and hottest) items…

Boost Your Portfolio With These Strong Buy Stocks

February 13, 2023
Expectations of the economy avoiding a recession have been rising amid the still-tight labor market and improving consumer sentiments. However, while uncertainties remain, quality stocks Walmart (WMT), AstraZeneca (AZN), and…

1 Tech Stock You’ll Wish You Bought Sooner

February 13, 2023
Leading cloud-based software company Salesforce (CRM) delivered double-digit top-line growth in its last reported quarter. Moreover, the company raised its guidance for fiscal 2023. CRM is well-positioned to achieve solid…

The Download: controversial gene therapy tests, and algorithms on trial

February 13, 2023
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. This biohacking company is using a crypto city to test controversial gene therapies Last year, biotech startup Minicircle started recruiting participants for a clinical trial of gene therapy. But several details made it…